Is There Need for a New Hepatitis B Vaccine Schedule for Children with Celiac Disease?

Ertekin V., Tosun M. S., SELİMOĞLU M. A.

HEPATITIS MONTHLY, cilt.11, sa.8, ss.634-637, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 8
  • Basım Tarihi: 2011
  • Doi Numarası: 10.5812/kowsar.1735143x.715
  • Dergi Adı: HEPATITIS MONTHLY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.634-637
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Celiac disease (CD) is an autoimmune disease characterized by immune-mediated inflammatory damage of the small intestinal mucosa, precipitated by the ingestion of gluten-containing foods. Since human leucocyte antigen DQ2 (HLA-DQ2) is a marker of nonresponsiveness to hepatits B virus (HBV) vaccine, CD may also be associated with this nonresponsiveness.